RxSight, Inc. (RXST) Tops Q1 EPS by 12c

RxSight, Inc. (NASDAQ: RXST) reported Q1 EPS of ($0.19), $0.12 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $30.9 million versus the consensus estimate of $29.75 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
• ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
• 20/20 BioLabs reports Q2 revenue growth, outlines Medicare strategy